-
-
JPMorgan reiterates Mirion Technologies stock rating on 2H26 outlook
-
Truist maintains Buy on James Hardie stock, cites cost synergies
-
Piper Sandler reiterates Inventiva stock rating on trial confidence
-
RBC Capital reiterates Corteva stock rating on seed spinoff outlook
-
Piper Sandler reiterates Coca-Cola stock rating on strong execution
-
JPMorgan reiterates Forgent Power Solutions stock rating on strong quarter
-
Climb Bio at Morgan Stanley conference: two lead drugs, long runway
-
Tessera increases stake in drone testing firm to 15%
-
Aktis Oncology at Morgan Stanley conference: platform bets and capital strength